Artemisinins inhibit oral candidiasis caused by Candida albicans through the repression on its hyphal development

Xiaoyue LIANG; Ding CHEN; Jiannan WANG; Binyou LIAO; Jiawei SHEN; Xingchen YE; Zheng WANG; Chengguang ZHU; Lichen GOU; Xinxuan ZHOU; Lei CHENG; Biao REN; Xuedong ZHOU.
International Journal of Oral Science ; (4): 40-40, 2023.
Artículo en Inglés | WPRIM | ID: wpr-1010695

Documentos relacionados

  1. Artemisinins inhibit oral candidiasis caused by Candida albicans through the repression on its hyphal development.
  2. Chemokine CCL28 Is a Potent Therapeutic Agent for Oropharyngeal Candidiasis.
  3. The Effects of Nutraceuticals and Herbal Medicine on Candida albicans in Oral Candidiasis: A Comprehensive Review.
  4. Mechanisms of antifungal resistance and developments in alternative strategies to combat Candida albicans infection.
  5. Azole potentiation in Candida species.
  6. Therapeutic effect of iturin A on <i>Candida albicans</i> oral infection and its pathogenic factors.
  7. Effectiveness of a tissue conditioner containing antifungals in a rat model of denture stomatitis.
  8. Ethyl caffeate combined with fluconazole exhibits efficacy against azole-resistant oropharyngeal candidiasis via the EFGR/JNK/c-JUN signaling pathway.
  9. <i>Chenopodium murale</i> Juice Shows Anti-Fungal Efficacy in Experimental Oral Candidiasis in Immunosuppressed Rats in Relation to Its Chemical Profile.
  10. Paeonol enhances treatment of fluconazole and amphotericin B against oropharyngeal candidiasis through HIF-1&#945; related IL-17 signaling.